Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study.

Kortuem KU, Zarranz-Ventura J, Bandello F, Duval R, O'Toole L, De Zanet S, Blair JPM, Seaman J, Zvolanek M, Jaeger K, Gmeiner B, Holz FG

Open source

DOI
10.1136/bjo-2024-327060
Published
2026 May 4
Container
The British journal of ophthalmology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bjo-2024-327060,
  title = {Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study.},
  author = {Kortuem KU and Zarranz-Ventura J and Bandello F and Duval R and O'Toole L and De Zanet S and Blair JPM and Seaman J and Zvolanek M and Jaeger K and Gmeiner B and Holz FG},
  year = {2026},
  journal = {The British journal of ophthalmology},
  doi = {10.1136/bjo-2024-327060},
  url = {https://doi.org/10.1136/bjo-2024-327060}
}

RIS

TY  - JOUR
TI  - Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study.
AU  - Kortuem KU
AU  - Zarranz-Ventura J
AU  - Bandello F
AU  - Duval R
AU  - O'Toole L
AU  - De Zanet S
AU  - Blair JPM
AU  - Seaman J
AU  - Zvolanek M
AU  - Jaeger K
AU  - Gmeiner B
AU  - Holz FG
PY  - 2026
JO  - The British journal of ophthalmology
DO  - 10.1136/bjo-2024-327060
UR  - https://doi.org/10.1136/bjo-2024-327060
ER  - 

APA

KU, K., J, Z., F, B., R, D., L, O., S, D. Z., JPM, B., J, S., M, Z., K, J., B, G., & FG, H. (2026). Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study.. The British journal of ophthalmology. https://doi.org/10.1136/bjo-2024-327060

Source records